Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

A Dual Catalytic Platform for Enabling sp3 α C–H Arylation & Alkylation of Benzamides

23 October 2019, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A dual catalytic sp3 a C–H arylation & alkylation of benzamides with organic halides is described. This protocol exhibits excellent chemoselectivity and exquisite site-selectivity, offering a complementary reactivity mode to existing sp3 arylation or alkylation events via either transition metal catalysis or photoredox events

Keywords

amides
arylation
alkylation
dual catalysis

Supplementary materials

Title
Description
Actions
Title
SI-final
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Now Published

Dual Catalytic Platform for Enabling sp3 α C–H Arylation and Alkylation of Benzamides [opens in a new tab]
Alexander W. Rand, Hongfei Yin, Liang Xu, Jessica Giacoboni, Raul Martin-Montero, Ciro Romano, John Montgomery, Ruben Martin journal article
ACS Catalysis , Volume 10, Issue 8
Online publication date: Mar 27, 2020

Version History

Oct 23, 2019 Version 1

Metrics

5,462
1,482
0
Views
Downloads
Citations

License

CC logo
CC
BY logo
BY
NC logo
NC
ND logo
ND
The content is available under CC BY NC ND 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv.10003277.v1
D O I: 10.26434/chemrxiv.10003277.v1 [opens in a new tab]

Funding

FEDER/MICIU –AEI/PGC2018-096839-B-100

Author’s competing interest statement

No conflict of interest

Share